Project Grant HT94252410463
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
The U.S. Defense Health Agency awarded a $2,534,532 Project Grant to Rush University Medical Center to evaluate evidence-based options for initial PTSD treatment non-responders. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a comprehensive range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The award has a performance period of September 1,...
The Defense Health Agency awarded a $724,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Duke University. The grant, titled "Targeting Dormancy-Associated Immune Tolerance to Eliminate Residual Breast Cancer," will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research, to be conducted at Duke University's Office of Research Administration Division from March...
The Defense Health Agency awarded $145,570 to Rice University under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 30, 2021 through September 29, 2023. The project aims to develop mutation-targeted immunotherapy for the treatment of rare cancers. Through this funding, Rice University researchers will investigate medical solutions for cancer on the battlefield and for the general public. The grant supports basic, applied, and advanced...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
This federal Project Grant award of $1,235,845.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research project led by the University of Illinois in Chicago. The project aims to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The award period runs from August 15, 2025 to August 14, 2028. The Military Medical Research and Development program funds...
This federal Project Grant award, valued at $1,306,778.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will support a research project titled "IMMUNOLOGIC DRIVERS OF LINEAGE BIAS IN TP53-MUTANT ACUTE LEUKEMIA" conducted by the University of...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...